Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Non-Current Debt: 2009-2025

Historic Non-Current Debt for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $577.2 million.

  • Pediatrix Medical's Non-Current Debt fell 498.42% to $577.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $577.2 million, marking a year-over-year decrease of 498.42%. This contributed to the annual value of $597.1 million for FY2024, which is 344.46% down from last year.
  • Latest data reveals that Pediatrix Medical reported Non-Current Debt of $577.2 million as of Q3 2025, which was down 498.42% from $583.9 million recorded in Q2 2025.
  • Pediatrix Medical's Non-Current Debt's 5-year high stood at $1.0 billion during Q3 2021, with a 5-year trough of $577.2 million in Q3 2025.
  • In the last 5 years, Pediatrix Medical's Non-Current Debt had a median value of $625.3 million in 2023 and averaged $696.8 million.
  • Per our database at Business Quant, Pediatrix Medical's Non-Current Debt plummeted by 4262.86% in 2021 and then tumbled by 202.04% in 2024.
  • Over the past 5 years, Pediatrix Medical's Non-Current Debt (Quarter) stood at $1.0 billion in 2021, then plummeted by 36.9% to $632.4 million in 2022, then fell by 2.21% to $618.4 million in 2023, then decreased by 3.44% to $597.1 million in 2024, then decreased by 3.34% to $577.2 million in 2025.
  • Its last three reported values are $577.2 million in Q3 2025, $583.9 million for Q2 2025, and $590.5 million during Q1 2025.